Catalyst Pharmaceutical Partners Inc buy StockNews.com
Start price
21.09.25
/
50%
€16.81
Target price
21.09.26
-
Performance (%)
1.10%
Price
22.09.25
€16.99
Summary
This prediction is currently active. With a performance of 1.10%, the BUY prediction by StockNews_com for Catalyst Pharmaceutical Partners Inc is trending in the right direction. This prediction currently runs until 21.09.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Catalyst Pharmaceutical Partners Inc | 1.10% |
| iShares Core DAX® | -0.560% |
| iShares Nasdaq 100 | 1.622% |
| iShares Nikkei 225® | 1.807% |
| iShares S&P 500 | 0.859% |
Comments by StockNews_com for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Catalyst Pharmaceuticals (NASDAQ:CPRX) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for CPRX provided by MarketBeat
Stopped prediction by StockNews_com for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€21.73
11.01.25
11.01.25
-
11.01.26
11.01.26
-21.81%
22.09.25
22.09.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.62
04.01.25
04.01.25
-
04.01.26
04.01.26
-17.60%
22.09.25
22.09.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€20.76
25.12.24
25.12.24
-
25.12.25
25.12.25
-18.16%
22.09.25
22.09.25
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€14.43
08.06.24
08.06.24
-
08.06.25
08.06.25
59.39%
09.06.25
09.06.25